Navigation Links
VCU Pauley Heart Center's 2009 Dr. Carolyn McCue Award for Woman Cardiologist of the Year Goes to Elizabeth G. Nabel, M.D.
Date:3/9/2010

Brigham and Women's Hospitals cardiologist, Elizabeth G. Nabel, M.D., named to prestigious national award

RICHMOND, Va., March 9 /PRNewswire-USNewswire/ -- Elizabeth G. Nabel, M.D., a nationally recognized physician-scientist and leading advocate of cardiovascular research, has been selected to receive the second annual Dr. Carolyn McCue Woman Cardiologist of the Year Award from the Virginia Commonwealth University Pauley Heart Center.

(Photo:  http://www.newscom.com/cgi-bin/prnh/20100309/DC67810 )

Nabel is the newly appointed president of Brigham and Women's Hospitals and a professor of medicine at Harvard Medical School. Prior to joining BWH in January 2010, she was director of the National Heart, Lung and Blood Institute, the largest of the National Institutes of Health institutes, where she oversaw a staff of 850 and an annual budget of $3 billion.

The McCue Award honors the memory of Dr. Carolyn McCue, one of the few female cardiologists of her time and a pioneer in the field of pediatric cardiology, who practiced at the Medical College of Virginia, now the VCU Medical Center, for 42 years. She created and chaired the school's Pediatric Cardiology Division for 20 years, during which time she was instrumental in establishing pediatric cardiology clinics in medically underserved communities throughout Virginia.

The McCue Award is made possible by a grant from the McCue family "to encourage and inspire other young women to pursue careers in cardiology." The award carries a $10,000 prize and will be presented at a ceremony in Richmond in April.

"Dr. Nabel exemplifies the bold determination and absolute commitment to advancing cardiology that the McCue Award celebrates," said Kenneth A. Ellenbogen, M.D., chair of the VCU School of Medicine Division of Cardiology. "She is an outstanding scholar, an innovative researcher and a skilled administrator. Throughout her distinguished career she has provided guidance and encouragement to countless medical students, trainees, junior faculty and fellow investigators. She is an inspiration to young women considering careers in cardiology, and to her colleagues and collaborators as well."

Nabel is a leading scientist in the development of novel genetic and cellular therapies for cardiovascular disease. A longtime proponent of the "bench-to-bedside" concept, she has used her well-rounded scientific background and strong management skills to bring research advances into clinical practice. She has been involved in community outreach programs throughout her career, including NHLB initiatives, with a particular focus on women and heart disease, such as the Heart Truth Campaign, and through the child obesity prevention program known as WE CAN.

Nabel has published more than 250 papers in leading medical journals. She is an elected member of the Institute of Medicine of the National Academy of Sciences. She also serves on the editorial board of the New England Journal of Medicine and is a consulting editor for Circulation and Circulation Research.

"The roster of candidates for the McCue Award this year was truly outstanding," said George W. Vetrovec, M.D., VCU professor of medicine and creator of the McCue Award Program. "We received nominations for many of the most accomplished women in cardiology, representing the top medical centers and healthcare organizations throughout the country. Each candidate was highly deserving, making the award selection process very challenging for our award panel."

Award Panel members included: George A. Beller, M.D., University of Virginia; Anne B. Curtis, M.D., University of South Florida; Pamela S. Douglas, M.D., Duke University; William C. Little, M.D., Wake Forest University School of Medicine; Mary Ann Peberdy, M.D., VCU; Kiran B. Sagar, M.D., University of Wisconsin; and George W. Vetrovec, M.D., VCU.

About the VCU Pauley Heart Center

The VCU Pauley Heart Center is recognized nationally for its heart failure and heart transplantation programs, and was among the first in the United States to implant the CardioWest temporary Total Artificial Heart, or TAH-t -- the only total artificial heart approved by the U.S. Food and Drug Administration. The heart center is comprised of the Divisions of Cardiology, Cardiothoracic Surgery and Pediatric Cardiology. There is close collaboration between the divisions to provide advanced, patient-centered care to patients of all ages, with every type of heart disease, with the best possible outcomes. Pauley Heart Center's superior performance resulted in its heart and heart surgery programs being ranked 44th in the country in US News Media Group's 2009 publication of America's Best Hospitals.

About VCU and the VCU Medical Center

Virginia Commonwealth University is a major, urban public research university with national and international rankings in sponsored research. Located on two downtown campuses in Richmond, VCU enrolls more than 32,000 students in 211 certificate and degree programs in the arts, sciences and humanities. Sixty-nine of the programs are unique in Virginia, many of them crossing the disciplines of VCU's 13 schools and one college. MCV Hospitals and the health sciences schools of Virginia Commonwealth University compose the VCU Medical Center, one of the nation's leading academic medical centers. For more, see www.vcu.edu.

SOURCE Virginia Commonwealth University

Back to top

RELATED LINKS
http://www.vcu.edu

'/>"/>

SOURCE Virginia Commonwealth University
Copyright©2010 PR Newswire.
All rights reserved

Related medicine news :

1. Orlando: June 13-16; National Convention on Mental Illness; Jane Pauley to Receive Award
2. NAMI Blog: PBS, MTV and Jane Pauley
3. New heart valve replacement technologies offer hope for high-risk patients
4. New method to grow arteries could lead to biological bypass for heart disease
5. Blacks, Hispanics With Heart Failure Less Likely to Use Hospice
6. Heart Aflutter? Remarkable New Images Show What it Looks Like in 4-D
7. Arterial disease awareness cuts heart attacks and leg amputations, claim UK vascular surgeons
8. Nalanda West Seattle and Jewel Heart Present Gelek Rimpoche: Fearless Compassion and Principles for a Happy Life
9. Increasing Soda Consumption Fuels Rise in Diabetes, Heart Disease
10. Processed Meat May Harm the Heart
11. Health Diagnostic Laboratory Inc. (HDL, Inc.) Launches Community Initiative, It Starts with the Heart
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... April 28, 2017 , ... Datta ... M.D. has joined the revolutionary endoscopic practice under Dr. Datta. Patel is a ... Pain Medicine. The patented, revolutionary eDiscSculpt Technique created and used by Datta Endoscopic ...
(Date:4/28/2017)... ... April 28, 2017 , ... People are starting to ... “Wearing a hearing aid doesn’t have the stigma it had when great-grandpa wore his ... of Greater Boston, in a NALA North American Speaker Series (NASS) segment. ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... the Brooke Grove Foundation implement a Microsoft Dynamics GP solution that integrates to ... ERP expert that specializes in long-term care, Brooke Grove now has the capability ...
(Date:4/28/2017)... ... 2017 , ... Christie Medical Holdings, Inc. , with its market-leading ... Medical Inc. , a leader in infusion therapy and pain management. , Intravenous ... percent of hospital patients receiving a peripheral IV catheter as part of their treatment ...
(Date:4/27/2017)... ... April 27, 2017 , ... The American Brain Foundation ... Leadership in Neurology Award (PLINA). The couple joins a prestigious list of past ... Walter Mondale, actor Michael J. Fox and former U.S. Attorney General Janet Reno. ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... , April 20, 2017 Research and ... Pharmaceutical Contract Manufacturing Services Market Analysis By Service (Manufacturing, Research), ... Forecasts, 2014 - 2025" report to their offering. ... The Latin American pharmaceutical ... billion by 2025 Low drug registration cost in ...
(Date:4/19/2017)... The Mobile X-Ray product segment is the most ... the forecast period Mobile X-Ray segment is the ... X-Ray devices market, which is estimated to be valued at ... CAGR of 7% over the forecast period. Mobile X-Ray segment ... US$ 100 Mn in 2017 over 2016. The segment,s revenue ...
(Date:4/19/2017)... Global Prostate Cancer Therapeutics Market: Overview ... cancer therapeutics market analyzes the current and future ... prostate cancer, launch of promising emerging therapies, as ... drugs & therapeutic biological products, and high growth ... side effects are some of the drivers expected ...
Breaking Medicine Technology: